Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

415
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
415
Cancer Vaccines01:30

Cancer Vaccines

913
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
913
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Cancer Survival Analysis01:21

Cancer Survival Analysis

620
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
620

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unveiling the impact of pipe materials on water hammer in pressure pipelines: an experimental and numerical study.

Scientific reports·2024
Same author

Structural, Optical, and Electrical Parameters of Doped PVA/PVP Blend with TPAI or THAI Salt.

Polymers·2023
Same author

Impact of ZnS/Mn on the Structure, Optical, and Electric Properties of PVC Polymer.

Polymers·2023
Same author

The role of purslane in modulating diverse effects of high fat diet on biochemical, histological, and molecular parameters of rats' liver.

Brazilian journal of biology = Revista brasleira de biologia·2021
Same author

The bioprotective role of irradiated hibiscus against harmful effects of using repeatedly frying edible oil.

Brazilian journal of biology = Revista brasleira de biologia·2021
Same author

Relationship of Plasma Vitamin-D Level with Left Ventricular Ejection Fraction in Patients with First Attack of Acute Myocardial Infarction.

Mymensingh medical journal : MMJ·2020

Related Experiment Video

Updated: Jan 5, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

614

Colorectal Cancer: An Update on Treatment Options and Future Perspectives.

R M Florescu-Ţenea1, A M Kamal2, P Mitruţ3,4

  • 1PhD Student, Department of Histology, University of Medicine and Pharmacy of Craiova, Romania.

Current Health Sciences Journal
|October 19, 2019
PubMed
Summary
This summary is machine-generated.

Colorectal cancer is a growing global health issue, now the third most diagnosed cancer. New targeted therapies show promise but have limitations, driving research into novel treatments.

Keywords:
Colorectal cancerbiomarkerscheckpoint inhibitorsimmunohistochemistry

More Related Videos

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.3K
Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
06:24

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

1.5K

Related Experiment Videos

Last Updated: Jan 5, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

614
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.3K
Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
06:24

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

1.5K

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Colorectal cancer (CRC) incidence is rising globally, becoming the third most diagnosed cancer and second leading cause of cancer death.
  • Screening and vaccination programs have reduced other cancer rates, highlighting a unique challenge with CRC.
  • Targeted therapies like bevacizumab and cetuximab represent a paradigm shift in CRC treatment, particularly for advanced or metastatic disease.

Observation:

  • Despite advances, targeted therapies offer limited or no benefit to a significant patient population.
  • The molecular mechanisms driving CRC's malignant phenotype are increasingly understood.
  • There is a continuous scientific effort to translate molecular insights into new therapeutic strategies.

Findings:

  • The limitations of current targeted therapies necessitate the exploration of novel treatment approaches.
  • Growing knowledge of CRC molecular drivers fuels the development of next-generation therapies.
  • Research is actively pursuing new treatments based on a deeper understanding of cancer biology.

Implications:

  • Developing novel therapies based on molecular mechanisms is crucial for improving CRC patient outcomes.
  • Addressing the limitations of current treatments will enhance the efficacy of colorectal cancer care.
  • Continued research into CRC molecular pathways promises to yield more effective and personalized treatment options.